Micelle BioPharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2018-01-01
- Employees
- 51
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 3
1 (50.0%)Dose-Finding Study of SC411 in Children With Sickle Cell Disease
- First Posted Date
- 2016-11-25
- Last Posted Date
- 2019-01-31
- Lead Sponsor
- Micelle BioPharma Inc
- Target Recruit Count
- 68
- Registration Number
- NCT02973360
- Locations
- 🇺🇸
Children's of Alabama - University of Alabama, Birmingham, Alabama, United States
🇺🇸UCSF Benioff Children's Hospital Oakland, Oakland, California, United States
🇺🇸University of Florida Health at Shands, Gainesville, Florida, United States
A Sickle CEll Disease ComplicatioN Trial
- First Posted Date
- 2015-11-13
- Last Posted Date
- 2019-02-01
- Lead Sponsor
- Micelle BioPharma Inc
- Target Recruit Count
- 210
- Registration Number
- NCT02604368
News
No news found